Production & Manufacturing
Manufacturing

Manufacturing News

View news from other Pharmaceutical sectors:
16-30 of 2334 results
Takeda to sell Techpool to Chinese JV partners
Takeda Pharmaceutical has agreed to divest its its majority shareholding of 51.34% in Guangdong Techpool Bio-Pharma (Techpool), a China-based firm focused on urinary protein biopharmaceuticals and production of biopharmaceuticals in critical care, to its joint venture (JV) partners for $280m.
Production & Manufacturing > Manufacturing > News
WuXi Biologics to establish $60m biologics manufacturing facility in Singapore
By PBR Staff Writer
Chinese firm WuXi Biologics has announced a S$80m ($60m) investment to set up an a biologics manufacturing facility in Singapore.
Production & Manufacturing > Manufacturing > News
Aquestive settles Suboxone drug patent infringement case with Par Pharmaceuticals
Aquestive Therapeutics has reached a settlement agreement resolving patent litigation related to Suboxone (buprenorphine and naloxone) Sublingual Film with Par Pharmaceuticals.
Production & Manufacturing > Manufacturing > News
Amryt, Aegerion sign expanded deal for Lojuxta capsules
Amryt has signed an agreement with Aegerion Pharmaceuticals to expand its exclusive licence agreement for Lojuxta (lomitapide) into Russia and the Commonwealth of Independent States (CIS), as well as the non-EU Balkan states.
Production & Manufacturing > Manufacturing > News
Takeda agrees to acquire Shire for £45.3bn
By PBR Staff Writer
Takeda Pharmaceutical has agreed to acquire Ireland-based rare disease biotech company Shire in a cash-cum stock deal worth around £45.3bn.
Production & Manufacturing > Manufacturing > News
Endo to buy Somerset Therapeutics for $190m
Endo International has agreed to acquire New Jersey-based Somerset Therapeutics, that develops and markets sterile injectable and ophthalmic drugs, and the business of its India-based affiliate Wintac, which operates as Somerset's contract developer and manufacturer.
Production & Manufacturing > Manufacturing > News
Shire considers Takeda's revised £46bn takeover offer
By PBR Staff Writer
Shire’s board said that it is willing to recommend Takeda Pharmaceutical’s revised acquisition offer of £46bn to its shareholders.
Production & Manufacturing > Manufacturing > News
Synpromics to partner with Lonza to improve biopharmaceuticals manufacturing
Synpromics has partnered with Lonza Pharma & Biotech to further develop its inducible promoter system and enhance manufacturing of biopharmaceuticals.
Production & Manufacturing > Manufacturing > News
Fresenius Kabi scraps $4.3bn merger with US generic drugmaker Akorn
By PBR Staff Writer
Germany-based Fresenius Kabi has scrapped its $4.3bn merger agreement with Akorn, saying that the US generic drugmaker did not fulfill various closing conditions.
Production & Manufacturing > Manufacturing > News
Alliance Pharma to divest 60% stake in Unigreg
Alliance Pharma's subsidiary Alliance Pharmaceuticals has agreed to sell its 60% interest in non-core Unigreg to its joint venture partner Pacific Glory Development for a consideration of £2.9m.
Production & Manufacturing > Manufacturing > News
Servier to buy Shire's oncology business for $2.4bn
By PBR Staff Writer
French pharmaceutical firm Servier has signed an agreement to acquire the oncology business of Shire for $2.4bn.
Production & Manufacturing > Manufacturing > News
Sanofi to invest €350m for new vaccine manufacturing facility in Canada
Sanofi will invest €350m to construct a new vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario.
Production & Manufacturing > Manufacturing > News
Helsinn to acquire global rights of Valchlor/Ledaga from Actelion Pharmaceuticals
Helsinn has agreed to acquire worldwide rights to Valchlor/Ledaga (mechlorethamine/chlormethine), an alkylating agent for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL), from Actelion Pharmaceuticals.
Production & Manufacturing > Manufacturing > News
Cipher to buy Cardiome Pharma's Canadian business portfolio
Cipher Pharmaceuticals has entered into a definitive arrangement agreement to acquire the Canadian business portfolio of Cardiome Pharma.
Production & Manufacturing > Manufacturing > News
Study says non-antibiotic drugs affect gut bacteria
By PBR Staff Writer
Researchers from European Molecular Biology Laboratory (EMBL) have revealed that one in four drugs with human targets could affect the growth of bacteria in the human gut.
Production & Manufacturing > Manufacturing > News
16-30 of 2334 results